‎Singapore: Mundipharma, an Asian pharmaceutical company, has launched Flutiform (fluticasone propionate/formotero...
Singapore: Alcon, the global leader in eye care and a division of Novartis, has recieved US FDA approval for Simbrinza s...
Singapore: Merck's grazoprevir/elbasvir, an investigational single tablet regimen for the treatment of chronic hepatitis...
Singapore: Japan-based Astellas Pharma and US-based FibroGen initiated a phase II clinical study in Japan of ASP1517/FG-...
Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its nove...
US-based Sprout Pharmaceuticals gained USFDA's approval for Addyi, whose chemical name is Flibanserin, created to enhanc...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Singapore: Gilead Sciences has submitted a new drug application (NDA) to the US FDA for the approval of Idelalisib, an i...
Singapore: Taiwan based TWi Pharmaceutical's drug candidate AC-203 has received designation of rare disease drug by Taiw...
Singapore: A*Star's Genome Institute of Singapore (GIS) have successfully converted human embryonic stem cells (hESCs) c...
Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee ...
Japanese pharmaceutical giant Eisai Co. Ltd. and Nihon Medi-Physics Co. Ltd. have entered into a collaboration agreement...
Singapore: French biopharmaceutical company, Poxel, an innovative drug developer for type 2 diabetes, has succesfully co...
Japan's leading pharmaceutical company Eisai Co. Ltd. has launched its in-house developed novel anticancer agent Lenvima...
Singapore: Isis Pharmaceuticals and AstraZeneca have made a strategic collaboration to discover and develop antisense th...
Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whethe...
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...
Singapore: Janssen-Cilag International NV (Janssen) submitted a marketing authorization application to the European Medi...
